Apollo Tyres Management Guidance Tracker
8 forward-looking guidance items tracked across 2 quarters.
Capex
Board approved ₹5,800 crore capex for expanding PCR and TBR capacities at the Andhra plant, spread over three financial years.
Q3 FY26Growth capex of ~₹2,000 crore in FY27TrackedGrowth capex for FY27 is expected to be about ₹2,000 crore, part of the overall ₹5,800 crore plan.
Q3 FY26Overall capex of ~₹3,000 crore in FY27TrackedTotal consolidated capex for FY27, including maintenance and Hungary expansion, is expected to be around ₹3,000 crore.
Q4 FY26FY27 capex of ₹3,500 crore, 80% for growthTrackedCapex of ₹3,500 crore planned for FY27, with nearly 80% allocated to capacity expansion in India and Hungary.
Margins
Elevated A&P spend in Q3 (₹150 crore) will normalize to about 2.5% of sales in a steady state from FY27 onwards.
Q4 FY26Europe margins to improve in H2 FY27 post restructuringTrackedPositive impact on European margins expected from H2 FY27 after Enschede closure and stabilization.
Q4 FY26Raw material costs to rise mid-to-high teens sequentially in Q1ActiveRaw material costs expected to increase mid-to-high teens in Q1 FY27 vs Q4 FY26, with further pressure possible in Q2.